Please use this identifier to cite or link to this item: http://nopr.niscpr.res.in/handle/123456789/12810
Full metadata record
DC FieldValueLanguage
dc.contributor.authorAnas, M-
dc.contributor.authorMohsin, M-
dc.contributor.authorSiddiqui, M-
dc.contributor.authorMannan, A-
dc.date.accessioned2011-10-05T09:34:10Z-
dc.date.available2011-10-05T09:34:10Z-
dc.date.issued2011-10-
dc.identifier.issn0975-1068 (Online); 0972-5938 (Print)-
dc.identifier.urihttp://hdl.handle.net/123456789/12810-
dc.description711-715en_US
dc.description.abstractAfter thorough review of literature, both from classical as well as modern medicine a clinical trial on a combination of herbal drugs was carried out in Diabetes mellitus. Herbal drugs are frequently used for various ailments since time immemorial without any known apparent side effects but these herbal drugs have not been scientifically evaluated so far. Keeping in mind India as a diabetic capital of the world, an attempt has been made to evaluate therapeutic efficacy of Unani formulation in the treatment of Diabetes mellitus. In this study, the formulation was given in powder form in 6 gm twice a day doses for 3 months in the diagnosed patient of Diabetes mellitus who has given written consent to participate in the study. The study was a comparative study and observations were analyzed statistically for the test of significance and results were promising.en_US
dc.language.isoen_USen_US
dc.publisherNISCAIR-CSIR, Indiaen_US
dc.relation.ispartofseriesInt. Cl.8: A01D 16/02en_US
dc.rights CC Attribution-Noncommercial-No Derivative Works 2.5 Indiaen_US
dc.sourceIJTK Vol.10(4) [October 2011]en_US
dc.subjectDiabetes mellitusen_US
dc.subjectPolyherbal formulationen_US
dc.subjectHyperglycaemiaen_US
dc.titleTherapeutic evaluation of a polyherbal formulation in type 2 Diabetes mellitusen_US
dc.typeArticleen_US
Appears in Collections:IJTK Vol.10(4) [October 2011]

Files in This Item:
File Description SizeFormat 
IJTK 10(4) 711-715.pdf66.67 kBAdobe PDFView/Open


Items in NOPR are protected by copyright, with all rights reserved, unless otherwise indicated.